日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PB2239: ACQUIRED VON WILLEBRAND DISEASE (AVWD) DIAGNOSTIC PROFILE IN MYELOPROLIFERATIVE NEOPLASIA (MN) PATIENTS IN WESTERN-ESTONIA

PB2239:爱沙尼亚西部骨髓增生性肿瘤(MN)患者获得性血管性血友病(AVWD)诊断特征

Matsumoto, K; Yasugi, T; Oki, A; Hoshiai, H; Taketani, Y; Kawana, T; Yoshikawa, H; Hurst, N G; Stocken, D D; Wilson, S; Keh, C; Wakelam, M J O; Ismail, T; Vaide, Ines; Aabrams, Virge; Laane, Edward

Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.

血清基质金属蛋白酶 9 与结直肠肿瘤:一项基于社区的潜在诊断测试评估

Wilson S, Damery S, Stocken D D, Dowswell G, Holder R, Ward S T, Redman V, Wakelam M J, James J, Hobbs F D R, Ismail T

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

胰腺癌辅助治疗中,5-氟尿嘧啶和亚叶酸钙与观察的比较:ESPAC-1 和 -3(v1) 试验的综合数据

Neoptolemos, J P; Stocken, D D; Tudur Smith, C; Bassi, C; Ghaneh, P; Owen, E; Moore, M; Padbury, R; Doi, R; Smith, D; Büchler, M W

Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients

血清基质金属蛋白酶 9 (MMP-9) 浓度升高可预测有症状患者是否存在结直肠肿瘤。

Hurst, N G; Stocken, D D; Wilson, S; Keh, C; Wakelam, M J O; Ismail, T

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

ESPAC-1随机对照试验中,切缘对接受辅助放化疗和/或化疗的胰腺癌患者生存率的影响

Neoptolemos, J P; Stocken, D D; Dunn, J A; Almond, J; Beger, H G; Pederzoli, P; Bassi, C; Dervenis, C; Fernandez-Cruz, L; Lacaine, F; Buckels, J; Deakin, M; Adab, F A; Sutton, R; Imrie, C; Ihse, I; Tihanyi, T; Olah, A; Pedrazzoli, S; Spooner, D; Kerr, D J; Friess, H; Büchler, M W